收藏切换
Research Progress of Anticancer Mechanism and Omics of Bufalin
收藏切换
Xiaofan WANG1, 2, Mohan ZHANG1, 2, Shicheng LIN1, 2, Yuxin ZHANG1, 2, Yicong LI1, 2, Kaiwen HU1, 2, Quanwang LI1, 2
Chinese Archives of Traditional Chinese Medicine | 2026, 44(5) : 125 - 131
Less
收藏切换
Chinese Archives of Traditional Chinese Medicine | 2026, 44(5): 125-131
• Target on National Project •
Research Progress of Anticancer Mechanism and Omics of Bufalin
Full
Xiaofan WANG1, 2, Mohan ZHANG1, 2, Shicheng LIN1, 2, Yuxin ZHANG1, 2, Yicong LI1, 2, Kaiwen HU1, 2, Quanwang LI1, 2
Affiliations
  • 1. Beijing University of Chinese Medicine, Beijing 100070, China
  • 2. Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100070, China
Published: 2026-05-10 doi: 10.13193/j.issn.1673-7717.2026.05.024
Outline
收藏切换

Cancer is still a major public health problem in the world, and it has become a serious threat to human health due to its refractory and high fatality rate. Traditional Chinese Medicine and its active ingredients have accumulated a lot of theoretical basis and practical experience in the treatment of malignant tumors. Bufalin is a cardiac glycoside compound isolated from the skin of Zhonghua Dachanchu (Bufo gargarizans) or Heikuang Chanchu (Bufo melanostictus) . Modern studies have proved that bufalin has broad-spectrum anti-cancer pharmacological activity against liver cancer, lung cancer, colorectal cancer, breast cancer and other tumors. Its anti-cancer mechanism mainly includes inhibition of tumor cell proliferation, invasion and metastasis, angiogenesis, cancer stem cancer, induction of apoptosis and autophagy, reversal of drug resistance, enhancement of chemotherapy sensitivity and immune function. The application and development of omics technology provide a new vision and strategy for studying the anti-tumor mechanism of bufalin. Therefore, this review included the latest research literature, updated the anti-cancer mechanism of bufalin, focused on the mechanism of genomics, transcriptomics, proteomics and metabolomics technology in the regulation of bufalin in the development of malignant tumors for the first time, and summarized the anti-cancer molecular mechanism of bufalin and the experimental results of traditional Chinese medicine based on related mechanisms and omics technology. The aim was to provide reference for further mechanism research and application of multiomics.

bufalin  /  anti-cancer  /  mechanism of action  /  omics technology  /  research progress
王潇凡, 张墨涵, 林事成, 张语馨, 李依聪, 胡凯文, 李泉旺. 蟾毒灵的抗癌作用机制及组学研究进展. 中华中医药学刊, 2026 , 44 (5) : 125 -131 . DOI: 10.13193/j.issn.1673-7717.2026.05.024
Xiaofan WANG, Mohan ZHANG, Shicheng LIN, Yuxin ZHANG, Yicong LI, Kaiwen HU, Quanwang LI. Research Progress of Anticancer Mechanism and Omics of Bufalin[J]. Chinese Archives of Traditional Chinese Medicine, 2026 , 44 (5) : 125 -131 . DOI: 10.13193/j.issn.1673-7717.2026.05.024
Year 2026 volume 44 Issue 5
81
14
Cite this Article
BibTeX
Article Info
doi: 10.13193/j.issn.1673-7717.2026.05.024
  • Online Date:2026-10-14
  • Published:2026-05-10
Article Data
Affiliations
History
Funding
Affiliations
    1. Beijing University of Chinese Medicine, Beijing 100070, China
    2. Dongfang Hospital, Beijing University of Chinese Medicine, Beijing 100070, China
References
Share
https://castjournals.cast.org.cn/joweb/zhzyyxk/EN/10.13193/j.issn.1673-7717.2026.05.024
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT